Differential Diagnosis and Prognosis of Fetuses with Bilateral Enlarged, Hyperechogenic Kidneys: Renal Volume and Amniotic Fluid Volume with Advancing Gestation.


Journal

Zeitschrift fur Geburtshilfe und Neonatologie
ISSN: 1439-1651
Titre abrégé: Z Geburtshilfe Neonatol
Pays: Germany
ID NLM: 9508901

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 8 9 2021
medline: 15 4 2022
entrez: 7 9 2021
Statut: ppublish

Résumé

This study's objective was to identify prenatal criteria helping differential diagnosis of bilateral enlarged, hyperechogenic kidneys, especially looking at development of renal volume and amniotic fluid volume with increasing gestational age. Retrospective analysis (single-center database) of all bilateral enlarged, hyperechogenic kidneys between 2000-2018. Renal enlargement was defined as renal volume>90 23 cases fulfilled the inclusion criteria. 12 pregnancies were terminated. For 11 continued pregnancies, longitudinal information on amniotic fluid volume and renal volume were available. 4 cases with oligohydramnios showed a progressive reduction; 6 cases with normal/increased amniotic fluid volume remained stable; in 1 case amniotic fluid volume normalized from initially being oligohydramnios. Regarding renal volume, 4 cases showed exponential enlargement, 3 cases linear progression; in 2 cases renal volume stabilized after initial progression; 2 cases showed initial progression and secondary regression. 4 fetuses survived: 3 autosomal dominant polycystic kidney diseases, 1 Bardet-Biedl syndrome. Progressive reduction of amniotic fluid volume with exponential increase of renal volume is highly suggestive for autosomal recessive polycystic kidney disease. Cases of autosomal dominant polycystic kidney disease show a linear progression of renal volume>90

Identifiants

pubmed: 34492706
doi: 10.1055/a-1586-5493
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

98-103

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest. The content of this paper was presented orally at the Annual Conference of Gynécologie Suisse (SGGG) in June 2019 in St. Gallen, Switzerland.

Auteurs

Ann-Katrin Morr (AK)

Department of Obstetrics, University Women's Hospital, Inselspital, Bern University Hospital, Bern, Switzerland.

Beatrice Mosimann (B)

Department of Obstetrics, University Women's Hospital, Inselspital, Bern University Hospital, Bern, Switzerland.

Sibylle Tschumi (S)

Department of Pediatric Nephrology, University Children's Hospital, Inselspital, Bern University Hospital, Bern, Switzerland.

Daniel Surbek (D)

Department of Obstetrics, University Women's Hospital, Inselspital, Bern University Hospital, Bern, Switzerland.

Luigi Raio (L)

Department of Obstetrics, University Women's Hospital, Inselspital, Bern University Hospital, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH